TNFSF10 and esophageal squamous cell carcinoma: In addition, TRAIL was significantly increased in advanced stages (IIB–IV) compared with the early stages (I–IIA; Fig. 1f, Supplementary Fig. 1a) and was negatively correlated with overall survival of patients with ESCC (Fig. 1g).